Roche (RHHBY), Johnson & Johnson (JNJ) and Gilead (GILD) each launched one drug in 2013 that was approved under the FDA’s new breakthrough therapy designation. Here’s what you need to know about their first quarter performance.
Roche (RHHBY), Johnson & Johnson (JNJ) and Gilead (GILD) each launched one drug in 2013 that was approved under the FDA’s new breakthrough therapy designation. Here’s what you need to know about their first quarter performance.